Browsing Tag
James McDonnell
1 post
Prescient Therapeutics secures FDA fast track for PTX-100 to advance CTCL treatment strategy
Find out how Prescient Therapeutics’ PTX-100 just gained FDA Fast Track status, accelerating the path to treating relapsed CTCL.